|
fatty infiltration liver , pegylation, hcv, plump latina , glycogen storage disorder, biliary tree, pegintron, scientific program, plump hardcore , plump women , fatty knees , fat asian girls , plump your pucker , antiviral drug, fda approved therapy, fatty acid molecule , alcoholism, fatty ratty , plump tits , mass spectrometry, hep c virus,
|
analysis was performed by using the chi-square dyslipidemias test. » Results Of the 88 patients (mean age 55.6 years; 49 women) followed up, 73 (mean age 53.1 years, range 38-68; 42 women) were recruited in the study; of these, 23 were in Group A, 28 in Group B, and 21 in Group C. Fifteen patients were excluded because of dyslipidemias fluctuating serum transaminase levels during the surveillance period (n=9), NSAID intake (n=4), or disagreement among radiologists about liver echo pattern (n=2). One patient in Group A dropped out during the second month of treatment because he moved to another city. There dyslipidemias was no significant change in serum transaminase levels and BMI during the 24-week surveillance period among the 72 patients. The three groups were matched for sex, age, transaminase levels and histological features [Table - 1] and [Table - 2]. [Table - 1] shows the changes in serum transaminase and lipid levels after each of the three treatments. These decreased significantly in all the three treatment groups (pUltrasonography showed normal liver echopattern at the end of treatment in 8 of 23 (35%) patients in Group A, in 17 of 28 (61%) patients in Group B, and in 18 of 21 (86%) patients in Group C; the rate of improvement was significant higher in Group C as compared to Group A (pAmong the 8 patients who underwent repeat liver biopsy after treatment, inflammation improved in 6 patients whereas fibrosis remained unchanged in all 8 patients.
|
